Amylyx Pharmaceutical
Amylyx Pharmaceutical is a combination of existing products founded in 2013 by Justin Klee.
2
Funding Rounds
$140.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Co*** | - | - | |
| Ju**** Kl** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Co*** | - | - | |
| Ju**** Kl** | - | - | |
| Pa** Fo****** | - | - | |
| Is*** Ch*** | - | - | - |
| Da**** Qu*** | - | - |
Funding
Funding series
Funding Series Analysis
The company Amylyx Pharmaceutical has raised a total of $140m in funding over 2 rounds.
Key Insights:
- Amylyx Pharmaceutical Series C round, July 2021: $135m
- Amylyx Pharmaceutical Series A round, August 2016: $5m
Amylyx Pharmaceutical Series C round, July 2021
$135m
Amylyx Pharmaceutical Series A round, August 2016
$5m
Industries
Amylyx Pharmaceutical is active in the following industries:
- Engineering
- Biomedical engineering
- Biotechnology
- Alzheimer's disease
- Neurodegenerative Disease
- Neuroscience
- Amyotrophic lateral sclerosis
- Neurotechnology
- Pharmaceutical industry